Atlas Trials

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

Clinical trial NCT03185793 · COMPLETED

Trial details

NCT number
NCT03185793
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2017-07-20
Primary completion
2018-07-20
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.